$SSY
SUNLINK HEALTH SYSTEMS INC Stock $ssy

$ssy Overview Financials Valuation SEC Filings Company Website

2013 Q2 Form 10-K Financial Statement

#000119312513382169 Filed on September 27, 2013

Income Statement

Concept	2013 Q2	2013	2012 Q2
Revenue	$25.45M	$120.1M	$26.63M
YoY Change	-4.46%	-2.59%	4061.41%
Cost Of Revenue	$4.280M	$5.920M	$4.910M
YoY Change	-12.83%	-25.61%	14.19%
Gross Profit	$21.25M	$114.2M	$21.72M
YoY Change	-2.16%	-1.0%	-693.44%
Gross Profit Margin	83.51%	95.07%	81.55%
Selling, General & Admin	$17.47M	$71.70M	$17.22M
YoY Change	1.45%	-27.79%	-777.95%
% of Gross Profit	82.21%	62.81%	79.28%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$4.050M	$4.048M	$1.020M
YoY Change	297.06%	-7.26%	-3.77%
% of Gross Profit	19.06%	3.55%	4.7%
Operating Expenses	$18.61M	$86.10M	$15.95M
YoY Change	16.68%	-24.34%	26483.33%
Operating Profit	$2.640M	-$1.856M	$5.770M
YoY Change	-54.25%	-186.09%	-255.11%
Interest Expense	-$290.0K	$1.533M	-$980.0K
YoY Change	-70.41%	-64.98%	-44.0%
% of Operating Profit	-10.98%		-16.98%
Other Income/Expense, Net	$90.00K	$4.947M	$0.00
YoY Change		-32.18%	-100.0%
Pretax Income	$2.350M	-$2.891M	$4.780M
YoY Change	-50.84%	29.0%	-125.39%
Income Tax	$720.0K	-$1.521M	$1.630M
% Of Pretax Income	30.64%		34.1%
Net Earnings	$2.163M	$4.488M	$5.114M
YoY Change	-57.7%	315.17%	-145.42%
Net Earnings / Revenue	8.5%	3.74%	19.2%
Basic Earnings Per Share	$0.23	$0.48	$0.54
Diluted Earnings Per Share	$0.23	$0.48	$0.54
COMMON SHARES
Basic Shares Outstanding	9.443M shares	9.445M shares	9.448M shares
Diluted Shares Outstanding	9.443M shares	9.445M shares	9.448M shares

Balance Sheet

Concept	2013 Q2	2013	2012 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$2.700M	$2.700M	$2.100M
YoY Change	28.57%	28.57%	-71.23%
Cash & Equivalents	$2.497M	$2.500M	$2.057M
Short-Term Investments
Other Short-Term Assets	$7.500M	$7.500M	$11.20M
YoY Change	-33.04%	-31.19%	-19.42%
Inventory	$3.798M	$3.800M	$3.884M
Prepaid Expenses
Receivables	$0.00	$12.40M	$13.23M
Other Receivables	$1.700M	$1.700M	$200.0K
Total Short-Term Assets	$28.09M	$28.10M	$30.62M
YoY Change	-8.25%	-8.17%	-29.45%
LONG-TERM ASSETS
Property, Plant & Equipment	$30.57M	$30.60M	$30.08M
YoY Change	1.64%	-0.97%	-10.74%
Goodwill	$461.0K		$461.0K
YoY Change	0.0%
Intangibles	$3.175M		$3.320M
YoY Change	-4.37%
Long-Term Investments
YoY Change
Other Assets	$1.587M	$5.700M	$894.0K
YoY Change	77.52%	-58.99%	-90.97%
Total Long-Term Assets	$39.91M	$39.90M	$48.55M
YoY Change	-17.8%	-17.9%	0.32%
TOTAL ASSETS
Total Short-Term Assets	$28.09M	$28.10M	$30.62M
Total Long-Term Assets	$39.91M	$39.90M	$48.55M
Total Assets	$68.00M	$68.00M	$79.17M
YoY Change	-14.11%	-14.14%	-13.76%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$5.474M	$5.500M	$6.934M
YoY Change	-21.06%	-20.29%	-7.55%
Accrued Expenses	$5.500M	$5.500M	$7.200M
YoY Change	-23.61%	-27.63%	-8.86%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$5.931M
YoY Change	-100.0%	-100.0%	11.91%
Long-Term Debt Due	$9.542M	$9.500M	$9.350M
YoY Change	2.05%	1.06%	345.24%
Total Short-Term Liabilities	$22.25M	$22.20M	$31.81M
YoY Change	-30.07%	-30.19%	1.64%
LONG-TERM LIABILITIES
Long-Term Debt	$8.728M	$8.700M	$13.74M
YoY Change	-36.48%	-36.5%	-53.58%
Other Long-Term Liabilities	$825.0K	$3.300M	$907.0K
YoY Change	-9.04%	-23.26%	-81.1%
Total Long-Term Liabilities	$12.01M	$12.00M	$18.07M
YoY Change	-33.5%	-33.33%	-47.48%
TOTAL LIABILITIES
Total Short-Term Liabilities	$22.25M	$22.20M	$31.81M
Total Long-Term Liabilities	$12.01M	$12.00M	$18.07M
Total Liabilities	$34.26M	$34.30M	$49.88M
YoY Change	-31.32%	-31.26%	-24.19%
SHAREHOLDERS EQUITY
Retained Earnings	$16.03M		$11.54M
YoY Change	38.88%
Common Stock	$4.722M		$4.724M
YoY Change	-0.04%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$33.74M	$33.70M	$29.30M
YoY Change
Total Liabilities & Shareholders Equity	$68.00M	$68.00M	$79.17M
YoY Change	-14.11%	-14.14%	-13.76%

Cashflow Statement

Concept	2013 Q2	2013	2012 Q2
OPERATING ACTIVITIES
Net Income	$2.163M	$4.488M	$5.114M
YoY Change	-57.7%	315.17%	-145.42%
Depreciation, Depletion And Amortization	$4.050M	$4.048M	$1.020M
YoY Change	297.06%	-7.26%	-3.77%
Cash From Operating Activities	$2.330M	-$2.016M	$3.740M
YoY Change	-37.7%	-165.41%	-48.63%
INVESTING ACTIVITIES
Capital Expenditures	-$2.820M	$4.791M	-$900.0K
YoY Change	213.33%	215.61%	233.33%
Acquisitions
YoY Change
Other Investing Activities	$800.0K	$18.39M	-$380.0K
YoY Change	-310.53%	-4376.74%	46.15%
Cash From Investing Activities	-$2.020M	$13.42M	-$1.270M
YoY Change	59.06%	-766.34%	139.62%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net		$213.0K
YoY Change
Debt Paid & Issued, Net		$17.41M
YoY Change		27.83%
Cash From Financing Activities	-370.0K	-10.96M	-1.280M
YoY Change	-71.09%	75.12%	412.0%
NET CHANGE
Cash From Operating Activities	2.330M	-2.016M	3.740M
Cash From Investing Activities	-2.020M	13.42M	-1.270M
Cash From Financing Activities	-370.0K	-10.96M	-1.280M
Net Change In Cash	-60.00K	440.0K	1.190M
YoY Change	-105.04%	-108.47%	-81.69%
FREE CASH FLOW
Cash From Operating Activities	$2.330M	-$2.016M	$3.740M
Capital Expenditures	-$2.820M	$4.791M	-$900.0K
Free Cash Flow	$5.150M	-$6.807M	$4.640M
YoY Change	10.99%	-535.23%	-38.54%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2013Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	9443408	shares
CY2012Q4	dei	Entity Public Float EntityPublicFloat	3549704
CY2010Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	5.19
CY2010Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	393624	shares
CY2010Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-301000
CY2010Q2	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	71000
CY2010Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	42692000
CY2010Q2	us-gaap	Accumulated Other Comprehensive Income Loss Defined Benefit Pension And Other Postretirement Plans Net Of Tax AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax	-301000
CY2010Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1704000
CY2011Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	168909	shares
CY2011Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	5.80
CY2011Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	174249	shares
CY2011Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	5.91
CY2011Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-278000
CY2011Q2	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	37000
CY2011Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	26068000
CY2011Q2	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	12317000
CY2011Q2	us-gaap	Defined Benefit Plan Benefit Obligation DefinedBenefitPlanBenefitObligation	1157000
CY2011Q2	us-gaap	Accumulated Other Comprehensive Income Loss Defined Benefit Pension And Other Postretirement Plans Net Of Tax AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax	-278000
CY2011Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	7250000
CY2011Q2	us-gaap	Defined Benefit Plan Fair Value Of Plan Assets DefinedBenefitPlanFairValueOfPlanAssets	1045000
CY2011Q3	us-gaap	Share Price SharePrice	1.90
CY2011Q3	ssy	Pre Payment On Credit Facility Term Loan PrePaymentOnCreditFacilityTermLoan	8000000
CY2012Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	9448000	shares
CY2012Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	220498	shares
CY2012Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	9448000	shares
CY2012Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	2.62
CY2012Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	400499	shares
CY2012Q2	us-gaap	Preferred Stock Share Subscriptions PreferredStockShareSubscriptions	2000000	shares
CY2012Q2	us-gaap	Common Stock No Par Value CommonStockNoParValue
CY2012Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	2000000	shares
CY2012Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	4.75
CY2012Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	12000000	shares
CY2011	us-gaap	Proceeds From Repayments Of Lines Of Credit ProceedsFromRepaymentsOfLinesOfCredit	5300000
CY2012Q2	us-gaap	Preferred Stock Value PreferredStockValue	0
CY2012Q2	us-gaap	Due To Other Related Parties Current And Noncurrent DueToOtherRelatedPartiesCurrentAndNoncurrent	644000
CY2012Q2	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	13740000
CY2012Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	33774000
CY2012Q2	us-gaap	Short Term Borrowings ShortTermBorrowings	5931000
CY2012Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	13521000
CY2012Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	6934000
CY2012Q2	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	2045000
CY2012Q2	us-gaap	Liabilities Current LiabilitiesCurrent	31814000
CY2012Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-497000
CY2012Q2	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	19000
CY2012Q2	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	4584000
CY2012Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	29291000
CY2012Q2	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	907000
CY2012Q2	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	9121000
CY2012Q2	us-gaap	Defined Benefit Plan Benefit Obligation DefinedBenefitPlanBenefitObligation	1536000
CY2012Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	11543000
CY2012Q2	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	0
CY2012Q2	us-gaap	Long Term Debt And Capital Lease Obligations LongTermDebtAndCapitalLeaseObligations	23090000
CY2012Q2	us-gaap	Common Stock Value CommonStockValue	4724000
CY2012Q2	us-gaap	Liabilities Of Disposal Group Including Discontinued Operation Noncurrent LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationNoncurrent	229000
CY2012Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	79172000
CY2012Q2	us-gaap	Capital Lease Obligations CapitalLeaseObligations	176000
CY2012Q2	us-gaap	Long Term Debt LongTermDebt	16086000
CY2012Q2	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	18067000
CY2012Q2	us-gaap	Liabilities Of Disposal Group Including Discontinued Operation Current LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent	2449000
CY2012Q2	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	2566000
CY2012Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2012Q2	us-gaap	Long Term Debt Current LongTermDebtCurrent	9350000
CY2012Q2	us-gaap	Deferred Tax Assets Goodwill And Intangible Assets DeferredTaxAssetsGoodwillAndIntangibleAssets	4273000
CY2012Q2	us-gaap	Receivables Net Current ReceivablesNetCurrent	13228000
CY2012Q2	us-gaap	Accumulated Other Comprehensive Income Loss Defined Benefit Pension And Other Postretirement Plans Net Of Tax AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax	-497000
CY2012Q2	us-gaap	Assets Current AssetsCurrent	30618000
CY2012Q2	us-gaap	Goodwill Goodwill	461000
CY2012Q2	us-gaap	Other Assets Miscellaneous Noncurrent OtherAssetsMiscellaneousNoncurrent	18472000
CY2012Q2	us-gaap	Income Taxes Receivable IncomeTaxesReceivable	198000
CY2012Q2	us-gaap	Defined Benefit Plan Amounts Recognized In Balance Sheet DefinedBenefitPlanAmountsRecognizedInBalanceSheet	-551000
CY2012Q2	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	3320000
CY2012Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	894000
CY2012Q2	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	5624000
CY2012Q2	us-gaap	Land Land	1949000
CY2012Q2	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	13110000
CY2013Q2	us-gaap	Preferred Stock Value PreferredStockValue	0
CY2012Q2	us-gaap	Assets Assets	79172000
CY2012Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2057000
CY2012Q2	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	22349000
CY2012Q2	us-gaap	Buildings And Improvements Gross BuildingsAndImprovementsGross	26942000
CY2012Q2	us-gaap	Escrow Deposit EscrowDeposit	0
CY2012Q2	us-gaap	Inventory Net InventoryNet	3884000
CY2012Q2	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	11065000
CY2012Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	63856000
CY2012Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	0
CY2012Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	4231000
CY2012Q2	us-gaap	Deferred Income Taxes And Other Assets Noncurrent DeferredIncomeTaxesAndOtherAssetsNoncurrent	5891000
CY2012Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	0
CY2012Q2	us-gaap	Defined Benefit Plan Accumulated Other Comprehensive Income Minimum Pension Liability Before Tax DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeMinimumPensionLiabilityBeforeTax	-798000
CY2012Q2	us-gaap	Defined Benefit Plan Fair Value Of Plan Assets DefinedBenefitPlanFairValueOfPlanAssets	985000
CY2012Q2	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Pensions DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsPensions	208000
CY2012Q2	us-gaap	Deferred Tax Assets Net Current DeferredTaxAssetsNetCurrent	5174000
CY2012Q2	us-gaap	Deferred Tax Assets Tax Deferred Expense Other DeferredTaxAssetsTaxDeferredExpenseOther	485000
CY2012Q2	us-gaap	Machinery And Equipment Gross MachineryAndEquipmentGross	34965000
CY2012Q2	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts	3217000
CY2012Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	30082000
CY2012Q2	ssy	Net Noncurrent Assets Of Subsidiary NetNoncurrentAssetsOfSubsidiary	7906000
CY2012Q2	ssy	Due To Third Party Payors DueToThirdPartyPayors	0
CY2012Q2	ssy	Net Current Assets Of Subsidiary NetCurrentAssetsOfSubsidiary	1846000
CY2012Q2	ssy	Deferred Tax Assets Depreciation Expense DeferredTaxAssetsDepreciationExpense	3385000
CY2012Q2	ssy	Professional Liability Risks Non Current ProfessionalLiabilityRisksNonCurrent	3191000
CY2012Q2	ssy	Deferred Tax Assets Deferred Gain On Incentive Reimbursements DeferredTaxAssetsDeferredGainOnIncentiveReimbursements	13000
CY2012Q2	ssy	Deferred Tax Assets Accrued Expenses DeferredTaxAssetsAccruedExpenses	2675000
CY2012Q2	ssy	Defined Benefit Plan Amounts Recognized In Prepaid Benefit Cost DefinedBenefitPlanAmountsRecognizedInPrepaidBenefitCost	247000
CY2013Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	9444000	shares
CY2013Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	404163	shares
CY2013Q2	us-gaap	Minority Interest Ownership Percentage By Parent MinorityInterestOwnershipPercentageByParent	1.00	pure
CY2013Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	9444000	shares
CY2013Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	1.92
CY2013Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	617499	shares
CY2013Q2	us-gaap	Preferred Stock Share Subscriptions PreferredStockShareSubscriptions	2000000	shares
CY2013Q2	us-gaap	Common Stock No Par Value CommonStockNoParValue
CY2013Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	2000000	shares
CY2013Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	3.18
CY2013Q2	us-gaap	Area Of Real Estate Property AreaOfRealEstateProperty	24.74	acre
CY2013Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	12000000	shares
CY2013Q2	us-gaap	Sale Of Stock Price Per Share SaleOfStockPricePerShare	1.50
CY2013Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal After Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive	6170000
CY2013Q2	us-gaap	Due To Other Related Parties Current And Noncurrent DueToOtherRelatedPartiesCurrentAndNoncurrent	216000
CY2013Q2	us-gaap	Capital Lease Obligations CapitalLeaseObligations	90000
CY2013Q2	us-gaap	Operating Leases Future Minimum Payments Due In Two Years OperatingLeasesFutureMinimumPaymentsDueInTwoYears	880000
CY2013Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	1731000
CY2013Q2	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	8728000
CY2013Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	34266000
CY2013Q2	us-gaap	Short Term Borrowings ShortTermBorrowings	0
CY2013Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	13396000
CY2013Q2	us-gaap	Operating Leases Future Minimum Payments Due OperatingLeasesFutureMinimumPaymentsDue	3052000
CY2013Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	5474000
CY2013Q2	us-gaap	Defined Benefit Plan Expected Future Benefit Payments Year Three DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree	60000
CY2013Q2	us-gaap	Defined Benefit Plan Expected Future Benefit Payments Next Twelve Months DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths	71000
CY2013Q2	us-gaap	Operating Leases Future Minimum Payments Due In Four Years OperatingLeasesFutureMinimumPaymentsDueInFourYears	439000
CY2013Q2	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	2151000
CY2013Q2	us-gaap	Liabilities Current LiabilitiesCurrent	22246000
CY2013Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-406000
CY2013Q2	us-gaap	Operating Leases Future Minimum Payments Due Thereafter OperatingLeasesFutureMinimumPaymentsDueThereafter	21000
CY2013Q2	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	229000
CY2013Q2	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	4121000
CY2013Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	33743000
CY2013Q2	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	825000
CY2013Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	9542000
CY2013Q2	us-gaap	Defined Benefit Plan Expected Future Benefit Payments Year Two DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo	57000
CY2013Q2	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	7761000
CY2013Q2	us-gaap	Defined Benefit Plan Benefit Obligation DefinedBenefitPlanBenefitObligation	1353000
CY2013Q2	us-gaap	Operating Leases Future Minimum Payments Due In Five Years OperatingLeasesFutureMinimumPaymentsDueInFiveYears	112000
CY2013Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive	180000
CY2013Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	16031000
CY2013Q2	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	1136000
CY2013Q2	us-gaap	Long Term Debt And Capital Lease Obligations LongTermDebtAndCapitalLeaseObligations	18270000
CY2013Q2	us-gaap	Common Stock Value CommonStockValue	4722000
CY2013Q2	us-gaap	Liabilities Of Disposal Group Including Discontinued Operation Noncurrent LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationNoncurrent	0
CY2013Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	68003000
CY2013Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	470000
CY2013Q2	us-gaap	Long Term Debt LongTermDebt	0
CY2013Q2	us-gaap	Operating Leases Future Minimum Payments Due In Three Years OperatingLeasesFutureMinimumPaymentsDueInThreeYears	507000
CY2013Q2	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	12014000
CY2013Q2	us-gaap	Liabilities Of Disposal Group Including Discontinued Operation Current LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent	0
CY2013Q2	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	1417000
CY2013Q2	us-gaap	Defined Benefit Plan Expected Future Benefit Payments Year Five DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive	66000
CY2013Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	177000
CY2013Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2013Q2	us-gaap	Operating Leases Future Minimum Payments Due Current OperatingLeasesFutureMinimumPaymentsDueCurrent	1093000
CY2013Q2	us-gaap	Long Term Debt Current LongTermDebtCurrent	9542000
CY2013Q2	us-gaap	Defined Benefit Plan Expected Future Benefit Payments Year Four DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour	62000
CY2013Q2	us-gaap	Deferred Tax Assets Goodwill And Intangible Assets DeferredTaxAssetsGoodwillAndIntangibleAssets	3762000
CY2013Q2	us-gaap	Receivables Net Current ReceivablesNetCurrent	12356000
CY2013Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive	450000
CY2013Q2	us-gaap	Assets Current AssetsCurrent	28093000
CY2013Q2	us-gaap	Accumulated Other Comprehensive Income Loss Defined Benefit Pension And Other Postretirement Plans Net Of Tax AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax	-406000
CY2013Q2	us-gaap	Goodwill Goodwill	461000
CY2013Q2	us-gaap	Other Assets Miscellaneous Noncurrent OtherAssetsMiscellaneousNoncurrent	9336000
CY2013Q2	us-gaap	Income Taxes Receivable IncomeTaxesReceivable	1769000
CY2013Q2	us-gaap	Defined Benefit Plan Amounts Recognized In Balance Sheet DefinedBenefitPlanAmountsRecognizedInBalanceSheet	-616000
CY2013Q2	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	3175000
CY2013Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	1587000
CY2013Q2	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	3279000
CY2013Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	145000
CY2013Q2	us-gaap	Land Land	1992000
CY2013Q2	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	10272000
CY2013Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	145000
CY2013Q2	us-gaap	Assets Assets	68003000
CY2013Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2497000
CY2013Q2	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	20117000
CY2013Q2	us-gaap	Buildings And Improvements Gross BuildingsAndImprovementsGross	29452000
CY2013Q2	us-gaap	Escrow Deposit EscrowDeposit	160000
CY2013Q2	us-gaap	Inventory Net InventoryNet	3798000
CY2013Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	145000
CY2013Q2	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	8121000
CY2013Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	64840000
CY2013Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	1175000
CY2013Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	0
CY2013Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	3505000
CY2013Q2	us-gaap	Deferred Income Taxes And Other Assets Noncurrent DeferredIncomeTaxesAndOtherAssetsNoncurrent	4113000
CY2013Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	0
CY2013Q2	us-gaap	Defined Benefit Plan Accumulated Other Comprehensive Income Minimum Pension Liability Before Tax DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeMinimumPensionLiabilityBeforeTax	-652000
CY2013Q2	us-gaap	Defined Benefit Plan Fair Value Of Plan Assets DefinedBenefitPlanFairValueOfPlanAssets	737000
CY2013Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	145000
CY2013Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	145000
CY2013Q2	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Pensions DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsPensions	313000
CY2013Q2	us-gaap	Deferred Tax Assets Net Current DeferredTaxAssetsNetCurrent	4008000
CY2013Q2	us-gaap	Deferred Tax Assets Tax Deferred Expense Other DeferredTaxAssetsTaxDeferredExpenseOther	564000
CY2013Q2	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions	82000
CY2013Q2	us-gaap	Machinery And Equipment Gross MachineryAndEquipmentGross	33396000
CY2013Q2	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts	2571000
CY2013Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	30574000
CY2013Q2	ssy	Plans Assets Invested In Fixed Income Investments PlansAssetsInvestedInFixedIncomeInvestments	0.16	pure
CY2013Q2	ssy	Reserve For Discontinued Operation ReserveForDiscontinuedOperation	0
CY2013Q2	ssy	Amount Of Installment AmountOfInstallment	150000
CY2013Q2	ssy	Long Term Debt Contractual Commitments For Interest In Year Three LongTermDebtContractualCommitmentsForInterestInYearThree	410000
CY2013Q2	ssy	Long Term Debt Contractual Commitments For Interest In Next Twelve Months LongTermDebtContractualCommitmentsForInterestInNextTwelveMonths	576000
CY2013Q2	ssy	Long Term Debt Contractual Commitments For Interest In Year After Five Year LongTermDebtContractualCommitmentsForInterestInYearAfterFiveYear	3588000
CY2013Q2	ssy	Net Noncurrent Assets Of Subsidiary NetNoncurrentAssetsOfSubsidiary	0
CY2013Q2	ssy	Due To Third Party Payors DueToThirdPartyPayors	556000
CY2011	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-25348000
CY2013Q2	ssy	Plan Expected To Pay In Pension Benefits Through Three Years PlanExpectedToPayInPensionBenefitsThroughThreeYears	321000
CY2013Q2	ssy	Plans Assets Invested In Equity Investments PlansAssetsInvestedInEquityInvestments	0.23	pure
CY2013Q2	ssy	Plans Assets Invested In Cash And Short Term Investments PlansAssetsInvestedInCashAndShortTermInvestments	0.61	pure
CY2013Q2	ssy	Net Current Assets Of Subsidiary NetCurrentAssetsOfSubsidiary	0
CY2013Q2	ssy	Long Term Debt Contractual Commitments For Interest In Year Five LongTermDebtContractualCommitmentsForInterestInYearFive	329000
CY2013Q2	ssy	Long Term Debt And Capital Lease Obligation Current And Non Current LongTermDebtAndCapitalLeaseObligationCurrentAndNonCurrent	18270000
CY2013Q2	ssy	Common Stock Shares Issued And Outstanding CommonStockSharesIssuedAndOutstanding	9443334	shares
CY2013Q2	ssy	Deferred Tax Assets Depreciation Expense DeferredTaxAssetsDepreciationExpense	2546000
CY2013Q2	ssy	Long Term Debt Contractual Commitments LongTermDebtContractualCommitments	5735000
CY2013Q2	ssy	Professional Liability Risks Non Current ProfessionalLiabilityRisksNonCurrent	2461000
CY2013Q2	ssy	Long Term Debt Contractual Commitments For Interest In Year Four LongTermDebtContractualCommitmentsForInterestInYearFour	338000
CY2013Q2	ssy	Long Term Debt Contractual Commitments For Interest In Year Two LongTermDebtContractualCommitmentsForInterestInYearTwo	494000
CY2013Q2	ssy	Deferred Tax Assets Deferred Gain On Incentive Reimbursements DeferredTaxAssetsDeferredGainOnIncentiveReimbursements	461000
CY2013Q2	ssy	Deferred Tax Assets Accrued Expenses DeferredTaxAssetsAccruedExpenses	1868000
CY2013Q2	ssy	Defined Benefit Plan Amounts Recognized In Prepaid Benefit Cost DefinedBenefitPlanAmountsRecognizedInPrepaidBenefitCost	36000
CY2012Q4	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	7400000
CY2012Q4	us-gaap	Proceeds From Divestiture Of Businesses ProceedsFromDivestitureOfBusinesses	9930000
CY2012Q4	ssy	Proceeds From Sale Of Business Unit Used To Pay Term Loan ProceedsFromSaleOfBusinessUnitUsedToPayTermLoan	5200000
CY2012Q4	ssy	Number Of Beds Sold NumberOfBedsSold	50	Beds
CY2011Q3	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement	2500000
CY2011Q3	ssy	Share Issued Under Private Placement ShareIssuedUnderPrivatePlacement	1329000	shares
CY2012Q4	ssy	Price Of Property Under Option To Purchase PriceOfPropertyUnderOptionToPurchase	1500000
CY2011	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.99
CY2011	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	8094000	shares
CY2011	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	0	shares
CY2011	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	5.41
CY2011	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.99
CY2011	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0.00
CY2011	us-gaap	Defined Benefit Plan Assumptions Used Calculating Net Periodic Benefit Cost Discount Rate DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate	0.0650	pure
CY2011	us-gaap	Defined Contribution Plan Employer Matching Contribution Percent DefinedContributionPlanEmployerMatchingContributionPercent	0.00	pure
CY2011	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	4779000
CY2011	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-2.01
CY2011	us-gaap	Defined Benefit Plan Assumptions Used Calculating Net Periodic Benefit Cost Expected Long Term Return On Assets DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets	0.0400	pure
CY2011	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	1.59
CY2011	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	0	shares
CY2011	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	8094000	shares
CY2011	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare	0.02
CY2011	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	40500	shares
CY2011	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	0.02
CY2011	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	-2.01
CY2011	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	178875	shares
CY2011	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	174000	shares
CY2011	us-gaap	Revenues Revenues	133197000
CY2011	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	0
CY2011	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-1250000
CY2011	us-gaap	Disposal Group Including Discontinued Operation Revenue DisposalGroupIncludingDiscontinuedOperationRevenue	40370000
CY2011	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-16080000
CY2011	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	356000
CY2011	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	1958000
CY2011	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	173000
CY2011	us-gaap	Investment Income Interest InvestmentIncomeInterest	5000
CY2011	us-gaap	Discontinued Operation Gain Loss From Disposal Of Discontinued Operation Before Income Tax DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax	438000
CY2011	us-gaap	Other Expenses OtherExpenses	277000
CY2011	us-gaap	Noncash Or Part Noncash Acquisition Value Of Assets Acquired1 NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1	205000
CY2011	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	588000
CY2011	us-gaap	Cost Of Services CostOfServices	8551000
CY2011	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions	34000
CY2011	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	3407000
CY2011	us-gaap	Charity Care Reimbursements Received CharityCareReimbursementsReceived	9535000
CY2011	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	23000
CY2011	us-gaap	Operating Income Loss OperatingIncomeLoss	-17920000
CY2011	us-gaap	Interest Paid InterestPaid	4025000
CY2011	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	265000
CY2011	us-gaap	Net Income Loss NetIncomeLoss	-16103000
CY2011	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	164000
CY2011	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	6000
CY2011	us-gaap	Discontinued Operation Income Loss From Discontinued Operation Before Income Tax DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax	79000
CY2011	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	0
CY2011	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	-16276000
CY2011	us-gaap	Sales Revenue Net SalesRevenueNet	120348000
CY2011	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	65000
CY2011	us-gaap	Increase Decrease In Restricted Cash IncreaseDecreaseInRestrictedCash	0
CY2011	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions	65000
CY2011	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	1775000
CY2011	us-gaap	Related Party Transaction Amounts Of Transaction RelatedPartyTransactionAmountsOfTransaction	896000
CY2011	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	0
CY2011	us-gaap	Income Tax Reconciliation Tax Settlements State And Local IncomeTaxReconciliationTaxSettlementsStateAndLocal	-1046000
CY2011	us-gaap	Cost Of Goods Sold CostOfGoodsSold	27835000
CY2011	us-gaap	Other Cost And Expense Operating OtherCostAndExpenseOperating	16520000
CY2011	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-7861000
CY2011	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	1000
CY2011	us-gaap	Share Based Compensation ShareBasedCompensation	6000
CY2011	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	1268000
CY2011	us-gaap	Deferred Compensation Arrangement With Individual Compensation Expense DeferredCompensationArrangementWithIndividualCompensationExpense	0
CY2011	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	5546000
CY2011	us-gaap	Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost	2000
CY2011	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	2370000
CY2011	us-gaap	Interest Expense InterestExpense	7433000
CY2011	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	-1788000
CY2011	us-gaap	Income Tax Reconciliation Nondeductible Expense Amortization IncomeTaxReconciliationNondeductibleExpenseAmortization	9000
CY2011	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-8674000
CY2011	us-gaap	Minority Interest Decrease From Redemptions MinorityInterestDecreaseFromRedemptions	-615000
CY2011	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-2640000
CY2011	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax	23000
CY2011	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	1485000
CY2011	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	0
CY2011	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	612000
CY2011	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	-1211000
CY2011	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	5344000
CY2011	us-gaap	Goodwill And Intangible Asset Impairment GoodwillAndIntangibleAssetImpairment	13347000
CY2011	us-gaap	Cash Provided By Used In Operating Activities Discontinued Operations CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations	588000
CY2013	dei	Entity Registrant Name EntityRegistrantName	SUNLINK HEALTH SYSTEMS INC
CY2013	dei	Entity Central Index Key EntityCentralIndexKey	0000096793
CY2013	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2013	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2013	dei	Amendment Flag AmendmentFlag	false
CY2013	dei	Entity Filer Category EntityFilerCategory	Smaller Reporting Company
CY2013	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2013
CY2013	dei	Document Type DocumentType	10-K
CY2013	dei	Document Period End Date DocumentPeriodEndDate	2013-06-30
CY2011	ssy	Increase Decrease In Deferred Gain IncreaseDecreaseInDeferredGain	-8244000
CY2011	ssy	Provision For Doubtful Accounts And Sales Return ProvisionForDoubtfulAccountsAndSalesReturn	12849000
CY2011	ssy	Payments To Acquire Property Plant And Equipment Continuing Operations PaymentsToAcquirePropertyPlantAndEquipmentContinuingOperations	2207000
CY2011	us-gaap	Depreciation Depreciation	4730000
CY2011	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	6000
CY2011	us-gaap	Labor And Related Expense LaborAndRelatedExpense	53563000
CY2011	us-gaap	Supplies Expense SuppliesExpense	9747000
CY2011	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	49000
CY2011	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-9072000
CY2011	ssy	Share Based Compensation Arrangement By Share Based Payments Award Options Grants In Period Range Of Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentsAwardOptionsGrantsInPeriodRangeOfExercisePrice	0.00
CY2011	ssy	Electronic Health Records Incentive Payments Recognized In Discontinued Operations ElectronicHealthRecordsIncentivePaymentsRecognizedInDiscontinuedOperations	0
CY2011	ssy	Discontinued Operation Income Tax Expense Benefit DiscontinuedOperationIncomeTaxExpenseBenefit	344000
CY2011	ssy	Assets Acquired Under Capital Lease Obligation Discontinued Operations AssetsAcquiredUnderCapitalLeaseObligationDiscontinuedOperations	0
CY2011	ssy	Payments To Acquire Property Plant And Equipment Discontinued Operations PaymentsToAcquirePropertyPlantAndEquipmentDiscontinuedOperations	433000
CY2011	ssy	Net Revenue Related To Settlements And Filings Of Prior Year Reports NetRevenueRelatedToSettlementsAndFilingsOfPriorYearReports	569000
CY2011	ssy	Increase Decrease In Third Party Payor Settlements IncreaseDecreaseInThirdPartyPayorSettlements	-210000
CY2011	ssy	Long Term Debt Issued As Payment In Kind For Interest Payable LongTermDebtIssuedAsPaymentInKindForInterestPayable	247000
CY2011	ssy	Increase Decrease Changes In Deferred Income Taxes IncreaseDecreaseChangesInDeferredIncomeTaxes	-7227000
CY2011	ssy	Other Comprehensive Income Minimum Pension Liabilities Net Adjustment Tax OtherComprehensiveIncomeMinimumPensionLiabilitiesNetAdjustmentTax	6000
CY2011	ssy	Other Comprehensive Income Loss Minimum Pension Liability Adjustment Net Of Tax OtherComprehensiveIncomeLossMinimumPensionLiabilityAdjustmentNetOfTax	23000
CY2011	ssy	Guarantee Expenses GuaranteeExpenses	202000
CY2013	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--06-30
CY2013	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2013	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2013	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P6Y
CY2013	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0089	pure
CY2013	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.48
CY2013	us-gaap	Stock Repurchased And Retired During Period Shares StockRepurchasedAndRetiredDuringPeriodShares	2631	shares
CY2013	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	9445000	shares
CY2013	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.80	pure
CY2013	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	0	shares
CY2013	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	2.13
CY2013	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.48
CY2013	us-gaap	Nature Of Operations NatureOfOperations	<div> <table style="BORDER-COLLAPSE: collapse" border="0" cellspacing="0" cellpadding="0" width="100%"> <tr> <td valign="top" width="3%" align="left"><font style="FONT-FAMILY: Times New Roman" size="2"><b>1.</b></font></td> <td valign="top" width="1%"><font size="1"> </font></td> <td valign="top" align="left"> <p align="justify"><font style="FONT-FAMILY: Times New Roman" size="2"><b>BUSINESS OPERATIONS</b></font></p> </td> </tr> </table> <!-- xbrl,body --> <p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: -6px"><font size="1"> </font></p> <p style="MARGIN-TOP: 0px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px" align="justify"><font style="FONT-FAMILY: Times New Roman" size="2">SunLink Health Systems, Inc. through subsidiaries (“SunLink”, “we”, “our”, “ours”, “us” or the “Company”), owns businesses which are providers of healthcare services in certain markets in the United States. SunLink’s business is composed of the ownership of two business segments:</font></p> <p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: -6px"><font size="1"> </font></p> <table style="BORDER-COLLAPSE: collapse" border="0" cellspacing="0" cellpadding="0" width="100%"> <tr> <td valign="top" width="3%" align="left"><font style="FONT-FAMILY: Times New Roman" size="2">•</font></td> <td valign="top" width="1%"> </td> <td valign="top" align="left"> <p align="left"><font style="FONT-FAMILY: Times New Roman" size="2">The Healthcare Facilities Segments is composed of three operational areas:</font></p> </td> </tr> </table> <p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: -6px"><font size="1"> </font></p> <table style="BORDER-COLLAPSE: collapse" border="0" cellspacing="0" cellpadding="0" width="100%"> <tr> <td width="4%"><font size="1"> </font></td> <td valign="top" width="3%" align="left"><font style="FONT-FAMILY: Times New Roman" size="2">–</font></td> <td valign="top" width="1%"><font size="1"> </font></td> <td valign="top" align="left"> <p align="justify"><font style="FONT-FAMILY: Times New Roman" size="2">Four community hospital subsidiaries in three states with a total of 232 licensed beds;</font></p> </td> </tr> </table> <p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: -6px"><font size="1"> </font></p> <table style="BORDER-COLLAPSE: collapse" border="0" cellspacing="0" cellpadding="0" width="100%"> <tr> <td width="4%"><font size="1"> </font></td> <td valign="top" width="3%" align="left"><font style="FONT-FAMILY: Times New Roman" size="2">–</font></td> <td valign="top" width="1%"><font size="1"> </font></td> <td valign="top" align="left"> <p align="justify"><font style="FONT-FAMILY: Times New Roman" size="2">Two nursing homes with a total of 166 licensed beds, each of which is located adjacent to, or in close proximity with a corresponding SunLink community hospital; and</font></p> </td> </tr> </table> <p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: -6px"><font size="1"> </font></p> <table style="BORDER-COLLAPSE: collapse" border="0" cellspacing="0" cellpadding="0" width="100%"> <tr> <td width="4%"><font size="1"> </font></td> <td valign="top" width="3%" align="left"><font style="FONT-FAMILY: Times New Roman" size="2">–</font></td> <td valign="top" width="1%"><font size="1"> </font></td> <td valign="top" align="left"> <p align="justify"><font style="FONT-FAMILY: Times New Roman" size="2">A Clanton, Alabama healthcare facility which is currently being repurposed for a multi-tenant medical park.</font></p> </td> </tr> </table> <p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: -6px"><font size="1"> </font></p> <table style="BORDER-COLLAPSE: collapse" border="0" cellspacing="0" cellpadding="0" width="100%"> <tr> <td valign="top" width="3%" align="left"><font style="FONT-FAMILY: Times New Roman" size="2">•</font></td> <td valign="top" width="1%"> </td> <td valign="top" align="left"> <p align="left"><font style="FONT-FAMILY: Times New Roman" size="2">The Specialty Pharmacy Segment is composed of four operational areas:</font></p> </td> </tr> </table> <p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: -6px"><font size="1"> </font></p> <table style="BORDER-COLLAPSE: collapse" border="0" cellspacing="0" cellpadding="0" width="100%"> <tr> <td width="4%"><font size="1"> </font></td> <td valign="top" width="3%" align="left"><font style="FONT-FAMILY: Times New Roman" size="2">–</font></td> <td valign="top" width="1%"><font size="1"> </font></td> <td valign="top" align="left"> <p align="justify"><font style="FONT-FAMILY: Times New Roman" size="2">Retail pharmacy products and services, all of which are conducted in rural markets;</font></p> </td> </tr> </table> <p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: -6px"><font size="1"> </font></p> <table style="BORDER-COLLAPSE: collapse" border="0" cellspacing="0" cellpadding="0" width="100%"> <tr> <td width="4%"><font size="1"> </font></td> <td valign="top" width="3%" align="left"><font style="FONT-FAMILY: Times New Roman" size="2">–</font></td> <td valign="top" width="1%"><font size="1"> </font></td> <td valign="top" align="left"> <p align="justify"><font style="FONT-FAMILY: Times New Roman" size="2">Institutional pharmacy services;</font></p> </td> </tr> </table> <p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: -6px"><font size="1"> </font></p> <table style="BORDER-COLLAPSE: collapse" border="0" cellspacing="0" cellpadding="0" width="100%"> <tr> <td width="4%"><font size="1"> </font></td> <td valign="top" width="3%" align="left"><font style="FONT-FAMILY: Times New Roman" size="2">–</font></td> <td valign="top" width="1%"><font size="1"> </font></td> <td valign="top" align="left"> <p align="justify"><font style="FONT-FAMILY: Times New Roman" size="2">Specialty pharmacy services; and</font></p> </td> </tr> </table> <p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: -6px"><font size="1"> </font></p> <table style="BORDER-COLLAPSE: collapse" border="0" cellspacing="0" cellpadding="0" width="100%"> <tr> <td width="4%"><font size="1"> </font></td> <td valign="top" width="3%" align="left"><font style="FONT-FAMILY: Times New Roman" size="2">–</font></td> <td valign="top" width="1%"><font size="1"> </font></td> <td valign="top" align="left"> <p align="justify"><font style="FONT-FAMILY: Times New Roman" size="2">Durable medical equipment.</font></p> </td> </tr> </table> <p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px"><font size="1"> </font></p> <p style="MARGIN-TOP: 0px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px" align="justify"><font style="FONT-FAMILY: Times New Roman" size="2">SunLink subsidiaries have conducted the healthcare facilities business since 2001 and the specialty pharmacy operations since April 2008. Our Specialty Pharmacy Segment currently is operated through Carmichael’s Cashway Pharmacy, Inc. (“Carmichael”), a subsidiary of our SunLink ScriptsRx, LLC subsidiary, and is composed of a specialty pharmacy business acquired in April 2008 with four service lines.</font></p> </div>
CY2013	us-gaap	Defined Benefit Plan Assumptions Used Calculating Net Periodic Benefit Cost Discount Rate DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate	0.0450	pure
CY2013	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	6073000
CY2013	us-gaap	Investment Income Interest InvestmentIncomeInterest	1000
CY2013	us-gaap	Discontinued Operation Gain Loss From Disposal Of Discontinued Operation Before Income Tax DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax	10450000
CY2013	us-gaap	Charity Care Reimbursements Received CharityCareReimbursementsReceived	9615000
CY2013	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	91000
CY2013	us-gaap	Operating Income Loss OperatingIncomeLoss	-1095000
CY2013	us-gaap	Interest Paid InterestPaid	1752000
CY2013	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0.00	pure
CY2013	us-gaap	Defined Benefit Plan Actuarial Gain Loss DefinedBenefitPlanActuarialGainLoss	41000
CY2013	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-2016000
CY2013	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-0.17
CY2013	us-gaap	Defined Benefit Plan Assumptions Used Calculating Net Periodic Benefit Cost Expected Long Term Return On Assets DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets	0.0400	pure
CY2013	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0.00
CY2013	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	260000	shares
CY2013	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	9445000	shares
CY2013	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare	0.64
CY2013	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P3Y4M6D
CY2013	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	-873000
CY2013	us-gaap	Allowance For Doubtful Accounts Receivable Period Increase Decrease AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease	12318000
CY2013	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	43000	shares
CY2013	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	617000	shares
CY2013	us-gaap	Net Income Loss NetIncomeLoss	4488000
CY2013	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-86000
CY2013	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	86000
CY2013	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	0	shares
CY2013	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<div> <p style="MARGIN-TOP: 0pt; TEXT-INDENT: 4%; FONT-FAMILY: Times New Roman; MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt"> <b><i>Concentrations of Credit Risk</i></b>—SunLink subsidiaries grant unsecured credit to their patients, most of who reside in the service area of the subsidiaries’ facilities and are insured under third-party agreements. Although SunLink’s two Georgia facilities generated approximately 52%, 51%, and 52% of gross revenues for the years ended June 30, 2013, 2012 and 2011, respectively, because of the geographic diversity of SunLink’s facilities and nongovernmental third-party payors, Medicare and Medicaid accounts represent SunLink’s only significant concentrations of credit risk. For SunLink’s Healthcare Facilities Segment, Medicare net revenues were approximately 41%, 41%, and 42% of net revenues for the years ended June 30, 2013, 2012 and 2011, respectively. For SunLink’s Healthcare Facilities Segment, Medicaid was approximately 15%, 17%, and 16% of net revenues for the years ended June 30, 2013, 2012 and 2011, respectively. For SunLink’s Healthcare Facilities Segment, Medicare receivables were approximately 44% and 36% of receivables—net at June 30, 2013 and 2012, respectively, while Medicaid receivables were approximately 15% and 26% of receivables—net at June 30, 2013 and 2012, respectively.</p> </div>
CY2013	us-gaap	Discontinued Operation Income Loss From Discontinued Operation Before Income Tax DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax	263000
CY2013	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	0.64
CY2013	us-gaap	Property Plant And Equipment Depreciation Methods PropertyPlantAndEquipmentDepreciationMethods	Depreciation is recognized over the estimated useful lives of the assets, which range from 3 to 45 years, on a straight-line basis.
CY2013	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	-0.17
CY2013	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	213000
CY2013	us-gaap	Use Of Estimates UseOfEstimates	<div> <p style="MARGIN-TOP: 12pt; TEXT-INDENT: 4%; FONT-FAMILY: Times New Roman; MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt"> <b><i>Management Estimates</i></b>—The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Some of the more significant estimates made by management involve reserves for adjustments to net patient service revenues, evaluation of the recoverability of assets, including accounts receivable and intangible assets, and the assessment of litigation and contingencies, including income taxes and related tax asset valuation allowances, all as discussed in more detail in the remainder of these notes to the consolidated financial statements. Actual results could differ materially from these estimates.</p> </div>
CY2013	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	1.22
CY2013	us-gaap	Property Plant And Equipment Estimated Useful Lives PropertyPlantAndEquipmentEstimatedUsefulLives	Estimated useful lives of the assets, which range from 3 to 45 years
CY2013	us-gaap	Defined Contribution Plan Employer Matching Contribution Percent DefinedContributionPlanEmployerMatchingContributionPercent	0.00	pure
CY2013	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue	1.22
CY2013	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	-1585000
CY2013	us-gaap	Revenues Revenues	120078000
CY2013	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	153000
CY2013	us-gaap	Disposal Group Including Discontinued Operation Revenue DisposalGroupIncludingDiscontinuedOperationRevenue	9748000
CY2013	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	218000
CY2013	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	4579000
CY2013	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-2891000
CY2013	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	0
CY2013	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	2116000
CY2013	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	17519000
CY2013	us-gaap	Sales Revenue Net SalesRevenueNet	108225000
CY2013	us-gaap	Increase Decrease In Restricted Cash IncreaseDecreaseInRestrictedCash	-160000
CY2013	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions	0
CY2013	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-3794000
CY2013	us-gaap	Related Party Transaction Amounts Of Transaction RelatedPartyTransactionAmountsOfTransaction	1004000
CY2013	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	789000
CY2013	us-gaap	Other Expenses OtherExpenses	4947000
CY2013	us-gaap	Noncash Or Part Noncash Acquisition Value Of Assets Acquired1 NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1	0
CY2013	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions	7000
CY2013	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-10963000
CY2013	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	106000
CY2013	us-gaap	Cost Of Services CostOfServices	7480000
CY2013	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	-13678000
CY2013	us-gaap	Income Tax Reconciliation Tax Settlements State And Local IncomeTaxReconciliationTaxSettlementsStateAndLocal	-476000
CY2013	us-gaap	Cost Of Goods Sold CostOfGoodsSold	22363000
CY2013	us-gaap	Other Cost And Expense Operating OtherCostAndExpenseOperating	15400000
CY2013	us-gaap	Cash Provided By Used In Operating Activities Discontinued Operations CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations	-1529000
CY2013	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	2914000
CY2013	us-gaap	Stock Repurchased And Retired During Period Value StockRepurchasedAndRetiredDuringPeriodValue	4000
CY2013	us-gaap	Defined Benefit Plan Actual Return On Plan Assets DefinedBenefitPlanActualReturnOnPlanAssets	1000
CY2013	us-gaap	Share Based Compensation ShareBasedCompensation	86000
CY2013	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	514000
CY2013	us-gaap	Deferred Compensation Arrangement With Individual Compensation Expense DeferredCompensationArrangementWithIndividualCompensationExpense	0
CY2013	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	213000
CY2013	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	440000
CY2013	us-gaap	Defined Benefit Plan Benefits Paid DefinedBenefitPlanBenefitsPaid	292000
CY2013	us-gaap	Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost	29000
CY2013	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	1918000
CY2013	us-gaap	Defined Contribution Plan Employer Discretionary Contribution Amount DefinedContributionPlanEmployerDiscretionaryContributionAmount	43000
CY2013	us-gaap	Interest Expense InterestExpense	1797000
CY2013	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	-1571000
CY2013	us-gaap	Income Tax Reconciliation Nondeductible Expense Amortization IncomeTaxReconciliationNondeductibleExpenseAmortization	0
CY2013	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-983000
CY2013	us-gaap	Defined Benefit Plan Interest Cost DefinedBenefitPlanInterestCost	68000
CY2013	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	13419000
CY2013	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax	91000
CY2013	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromCurrentPeriodTaxPositions	1000
CY2013	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	4048000
CY2013	us-gaap	Goodwill And Intangible Asset Impairment GoodwillAndIntangibleAssetImpairment	0
CY2013	us-gaap	Proceeds From Repayments Of Lines Of Credit ProceedsFromRepaymentsOfLinesOfCredit	-5931000
CY2013	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	222000
CY2013	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	12699000
CY2013	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	145000
CY2013	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	-4220000
CY2013	us-gaap	Depreciation Depreciation	3903000
CY2013	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	86000
CY2013	us-gaap	Labor And Related Expense LaborAndRelatedExpense	52660000
CY2013	us-gaap	Defined Benefit Plan Contributions By Employer DefinedBenefitPlanContributionsByEmployer	43000
CY2013	us-gaap	Supplies Expense SuppliesExpense	9095000
CY2013	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	18000
CY2013	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-1306000
CY2013	ssy	Share Based Compensation Arrangement By Share Based Payments Award Options Grants In Period Range Of Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentsAwardOptionsGrantsInPeriodRangeOfExercisePrice	1.22
CY2013	ssy	Discontinued Operation Income Tax Expense Benefit DiscontinuedOperationIncomeTaxExpenseBenefit	4640000
CY2013	ssy	Unrecognized Actuarial Loss UnrecognizedActuarialLoss	652000
CY2013	ssy	Stock Issued During Period Value Bonus Shares StockIssuedDuringPeriodValueBonusShares	100000
CY2013	ssy	Redemption Of Rights Price RedemptionOfRightsPrice	0.001
CY2013	ssy	Expected Return On Investment ExpectedReturnOnInvestment	0.04	pure
CY2013	ssy	Other Comprehensive Income Minimum Pension Liabilities Net Adjustment Tax OtherComprehensiveIncomeMinimumPensionLiabilitiesNetAdjustmentTax	55000
CY2013	ssy	Other Comprehensive Income Loss Minimum Pension Liability Adjustment Net Of Tax OtherComprehensiveIncomeLossMinimumPensionLiabilityAdjustmentNetOfTax	91000
CY2013	ssy	Prepaid Benefit Cost PrepaidBenefitCost	36000
CY2013	ssy	Assets Acquired Under Capital Lease Obligation Discontinued Operations AssetsAcquiredUnderCapitalLeaseObligationDiscontinuedOperations	0
CY2013	ssy	Financing Costs And Expenses FinancingCostsAndExpenses	2710000
CY2013	ssy	Net Operating Loss Carryforward Expiration Year NetOperatingLossCarryforwardExpirationYear	2023
CY2013	ssy	Funded Status Of Plans FundedStatusOfPlans	616000
CY2013	ssy	Payments To Acquire Property Plant And Equipment Discontinued Operations PaymentsToAcquirePropertyPlantAndEquipmentDiscontinuedOperations	45000
CY2013	ssy	Share Based Payment Award Options Exercises In Period Range Of Exercise Price ShareBasedPaymentAwardOptionsExercisesInPeriodRangeOfExercisePrice	0.00
CY2013	ssy	Net Revenue Related To Settlements And Filings Of Prior Year Reports NetRevenueRelatedToSettlementsAndFilingsOfPriorYearReports	166000
CY2013	ssy	Increase Decrease In Third Party Payor Settlements IncreaseDecreaseInThirdPartyPayorSettlements	-1032000
CY2013	ssy	Long Term Debt Issued As Payment In Kind For Interest Payable LongTermDebtIssuedAsPaymentInKindForInterestPayable	0
CY2013	ssy	Increase Decrease Changes In Deferred Income Taxes IncreaseDecreaseChangesInDeferredIncomeTaxes	2944000
CY2013	ssy	Age Of Participants To Take Monthly Pension Benefits AgeOfParticipantsToTakeMonthlyPensionBenefits	65	Age
CY2013	ssy	Guarantee Expenses GuaranteeExpenses	137000
CY2013	ssy	Number Of Physicians Under Guarantee Agreements NumberOfPhysiciansUnderGuaranteeAgreements	1	Physician
CY2013	ssy	Number Of Stockholders To Whom Shares Issued NumberOfStockholdersToWhomSharesIssued	68	Stockholders
CY2013	ssy	Additional Income Tax Expense AdditionalIncomeTaxExpense	0
CY2013	ssy	Increase Decrease In Deferred Gain IncreaseDecreaseInDeferredGain	-1135000
CY2013	ssy	Provision For Doubtful Accounts And Sales Return ProvisionForDoubtfulAccountsAndSalesReturn	11853000
CY2013	ssy	Number Of Stockholders NumberOfStockholders	480	Stockholders
CY2013	ssy	Payments To Acquire Property Plant And Equipment Continuing Operations PaymentsToAcquirePropertyPlantAndEquipmentContinuingOperations	4975000
CY2013	ssy	Loss Contingency Lawsuit Date LossContingencyLawsuitDate	2007-12-07
CY2013	ssy	Maximum Period Of Accounts Receivable Written Off MaximumPeriodOfAccountsReceivableWrittenOff	P120D
CY2013	ssy	Maximum Number Of Record Holders Under Odd Lot Tender Offer MaximumNumberOfRecordHoldersUnderOddLotTenderOffer	300	Stockholders
CY2013	ssy	Stock Repurchased And Retired During Period Bonus Value StockRepurchasedAndRetiredDuringPeriodBonusValue	7000
CY2013	ssy	Stock Repurchased And Retired During Period Fee And Expense Value StockRepurchasedAndRetiredDuringPeriodFeeAndExpenseValue	184000
CY2013	ssy	Stock Repurchased And Retired During Period Aggregate Value StockRepurchasedAndRetiredDuringPeriodAggregateValue	195000
CY2013	ssy	Maximum Number Of Shares Held By Stockholders Under Tender Offer MaximumNumberOfSharesHeldByStockholdersUnderTenderOffer	99	shares
CY2013	ssy	Number Of Law Firms Related To Entities NumberOfLawFirmsRelatedToEntities	2	pure
CY2012	us-gaap	Line Of Credit Facility Initiation Date1 LineOfCreditFacilityInitiationDate1	2008-04-23
CY2012	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0134	pure
CY2012	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.12
CY2012	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	9350000	shares
CY2012	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.76	pure
CY2012	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	0
CY2012	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	-1676000
CY2012	us-gaap	Sales Revenue Net SalesRevenueNet	113189000
CY2012	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	2342000
CY2012	us-gaap	Increase Decrease In Restricted Cash IncreaseDecreaseInRestrictedCash	0
CY2012	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	0.29
CY2012	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	411000	shares
CY2012	us-gaap	Revenues Revenues	123269000
CY2012	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	-0.18
CY2012	us-gaap	Allowance For Doubtful Accounts Receivable Period Increase Decrease AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease	10685000
CY2012	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	23750	shares
CY2012	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0.00
CY2012	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	250000	shares
CY2012	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	9350000	shares
CY2012	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare	0.29
CY2012	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	0	shares
CY2012	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	0	shares
CY2012	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	2.67
CY2012	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.12
CY2012	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P6Y
CY2012	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	1.97
CY2012	us-gaap	Defined Benefit Plan Assumptions Used Calculating Net Periodic Benefit Cost Discount Rate DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate	0.0650	pure
CY2012	us-gaap	Defined Contribution Plan Employer Matching Contribution Percent DefinedContributionPlanEmployerMatchingContributionPercent	0.00	pure
CY2012	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue	2.09
CY2012	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0.00	pure
CY2012	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	3082000
CY2012	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-0.18
CY2012	us-gaap	Defined Benefit Plan Assumptions Used Calculating Net Periodic Benefit Cost Expected Long Term Return On Assets DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets	0.0400	pure
CY2012	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	352000
CY2012	us-gaap	Disposal Group Including Discontinued Operation Revenue DisposalGroupIncludingDiscontinuedOperationRevenue	34709000
CY2012	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	862000
CY2012	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-2241000
CY2012	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-20000
CY2012	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	-1242000
CY2012	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	13622000
CY2012	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	2757000
CY2012	us-gaap	Investment Income Interest InvestmentIncomeInterest	14000
CY2012	us-gaap	Discontinued Operation Gain Loss From Disposal Of Discontinued Operation Before Income Tax DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax	0
CY2012	us-gaap	Charity Care Reimbursements Received CharityCareReimbursementsReceived	9566000
CY2012	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-219000
CY2012	us-gaap	Operating Income Loss OperatingIncomeLoss	2156000
CY2012	us-gaap	Interest Paid InterestPaid	4029000
CY2012	us-gaap	Defined Benefit Plan Actuarial Gain Loss DefinedBenefitPlanActuarialGainLoss	350000
CY2012	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	-3000000
CY2012	us-gaap	Net Income Loss NetIncomeLoss	1081000
CY2012	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-204000
CY2012	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	92000
CY2012	us-gaap	Discontinued Operation Income Loss From Discontinued Operation Before Income Tax DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax	4108000
CY2012	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	1328000
CY2012	us-gaap	Defined Benefit Plan Benefits Paid DefinedBenefitPlanBenefitsPaid	44000
CY2012	us-gaap	Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost	31000
CY2012	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	2191000
CY2012	us-gaap	Interest Expense InterestExpense	4391000
CY2012	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions	2342000
CY2012	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-1833000
CY2012	us-gaap	Related Party Transaction Amounts Of Transaction RelatedPartyTransactionAmountsOfTransaction	1092000
CY2012	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	0
CY2012	us-gaap	Other Expenses OtherExpenses	7294000
CY2012	us-gaap	Noncash Or Part Noncash Acquisition Value Of Assets Acquired1 NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1	80000
CY2012	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions	18000
CY2012	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-6261000
CY2012	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	-33000
CY2012	us-gaap	Cost Of Services CostOfServices	7958000
CY2012	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	-13881000
CY2012	us-gaap	Income Tax Reconciliation Tax Settlements State And Local IncomeTaxReconciliationTaxSettlementsStateAndLocal	-9000
CY2012	us-gaap	Cost Of Goods Sold CostOfGoodsSold	26073000
CY2012	us-gaap	Other Cost And Expense Operating OtherCostAndExpenseOperating	15661000
CY2012	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	203000
CY2012	us-gaap	Defined Benefit Plan Actual Return On Plan Assets DefinedBenefitPlanActualReturnOnPlanAssets	-16000
CY2012	us-gaap	Share Based Compensation ShareBasedCompensation	92000
CY2012	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	605000
CY2012	us-gaap	Deferred Compensation Arrangement With Individual Compensation Expense DeferredCompensationArrangementWithIndividualCompensationExpense	0
CY2012	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-5193000
CY2012	us-gaap	Income Tax Reconciliation Nondeductible Expense Amortization IncomeTaxReconciliationNondeductibleExpenseAmortization	316000
CY2012	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-909000
CY2012	us-gaap	Minority Interest Decrease From Redemptions MinorityInterestDecreaseFromRedemptions	-73000
CY2012	us-gaap	Defined Benefit Plan Interest Cost DefinedBenefitPlanInterestCost	73000
CY2012	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-2014000
CY2012	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax	-219000
CY2012	us-gaap	Asset Impairment Charges AssetImpairmentCharges	931000
CY2012	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	4365000
CY2012	us-gaap	Goodwill And Intangible Asset Impairment GoodwillAndIntangibleAssetImpairment	931000
CY2012	us-gaap	Proceeds From Repayments Of Lines Of Credit ProceedsFromRepaymentsOfLinesOfCredit	631000
CY2012	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	201000
CY2012	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	4388000
CY2012	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	157000
CY2012	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	-768000
CY2012	us-gaap	Cash Provided By Used In Operating Activities Discontinued Operations CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations	1993000
CY2012	us-gaap	Depreciation Depreciation	4207000
CY2012	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	92000
CY2012	us-gaap	Labor And Related Expense LaborAndRelatedExpense	52115000
CY2012	us-gaap	Defined Benefit Plan Contributions By Employer DefinedBenefitPlanContributionsByEmployer	0
CY2012	us-gaap	Supplies Expense SuppliesExpense	8428000
CY2012	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	39000
CY2012	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-565000
CY2012	ssy	Discontinued Operation Income Tax Expense Benefit DiscontinuedOperationIncomeTaxExpenseBenefit	1351000
CY2012	ssy	Prepaid Benefit Cost PrepaidBenefitCost	247000
CY2012	ssy	Assets Acquired Under Capital Lease Obligation Discontinued Operations AssetsAcquiredUnderCapitalLeaseObligationDiscontinuedOperations	349000
CY2012	ssy	Funded Status Of Plans FundedStatusOfPlans	551000
CY2012	ssy	Payments To Acquire Property Plant And Equipment Discontinued Operations PaymentsToAcquirePropertyPlantAndEquipmentDiscontinuedOperations	496000
CY2012	ssy	Share Based Payment Award Options Exercises In Period Range Of Exercise Price ShareBasedPaymentAwardOptionsExercisesInPeriodRangeOfExercisePrice	0.00
CY2012	ssy	Net Revenue Related To Settlements And Filings Of Prior Year Reports NetRevenueRelatedToSettlementsAndFilingsOfPriorYearReports	547000
CY2012	ssy	Increase Decrease In Third Party Payor Settlements IncreaseDecreaseInThirdPartyPayorSettlements	-33000
CY2013Q1	us-gaap	Sales Revenue Net SalesRevenueNet	29240000
CY2012Q1	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-0.18
CY2012Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	9448000	shares
CY2012Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.16
CY2012Q1	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	-0.18
CY2012Q1	us-gaap	Net Income Loss NetIncomeLoss	-1543000
CY2012Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	9448000	shares
CY2012Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.16
CY2012	ssy	Long Term Debt Issued As Payment In Kind For Interest Payable LongTermDebtIssuedAsPaymentInKindForInterestPayable	105000
CY2012	ssy	Increase Decrease Changes In Deferred Income Taxes IncreaseDecreaseChangesInDeferredIncomeTaxes	568000
CY2012	ssy	Other Comprehensive Income Minimum Pension Liabilities Net Adjustment Tax OtherComprehensiveIncomeMinimumPensionLiabilitiesNetAdjustmentTax	133000
CY2012	ssy	Other Comprehensive Income Loss Minimum Pension Liability Adjustment Net Of Tax OtherComprehensiveIncomeLossMinimumPensionLiabilityAdjustmentNetOfTax	-219000
CY2012	ssy	Unrecognized Actuarial Loss UnrecognizedActuarialLoss	798000
CY2012	ssy	Guarantee Expenses GuaranteeExpenses	340000
CY2012	ssy	Increase Decrease In Deferred Gain IncreaseDecreaseInDeferredGain	8348000
CY2012	ssy	Provision For Doubtful Accounts And Sales Return ProvisionForDoubtfulAccountsAndSalesReturn	10080000
CY2012	ssy	Payments To Acquire Property Plant And Equipment Continuing Operations PaymentsToAcquirePropertyPlantAndEquipmentContinuingOperations	1518000
CY2013Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.02
CY2013Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	9446000	shares
CY2013Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.02
CY2013Q1	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-0.02
CY2013Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	9446000	shares
CY2013Q1	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	-0.02
CY2013Q1	us-gaap	Net Income Loss NetIncomeLoss	-186000
CY2013Q1	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	-197000
CY2012Q1	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	-1684000
CY2012Q1	us-gaap	Sales Revenue Net SalesRevenueNet	31354000
CY2011Q2	ssy	Amount Of Funds Received From Medicare Electronic Health Records AmountOfFundsReceivedFromMedicareElectronicHealthRecords	790000
CY2012Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.54
CY2012Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	9448000	shares
CY2012Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.54
CY2012Q2	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	0.33
CY2012Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	9448000	shares
CY2012Q2	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	0.33
CY2012Q2	us-gaap	Net Income Loss NetIncomeLoss	5114000
CY2012Q2	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	3148000
CY2012Q2	us-gaap	Sales Revenue Net SalesRevenueNet	26633000
CY2012Q2	ssy	Amount Of Funds Received From Medicaid Electronic Health Records AmountOfFundsReceivedFromMedicaidElectronicHealthRecords	188000
CY2013Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.23
CY2013Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	9443000	shares
CY2013Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.23
CY2013Q2	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	0.17
CY2013Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	9443000	shares
CY2013Q2	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	0.17
CY2013Q2	us-gaap	Net Income Loss NetIncomeLoss	2163000
CY2013Q2	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	1629000
CY2013Q2	us-gaap	Sales Revenue Net SalesRevenueNet	25445000
CY2011Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.18
CY2011Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	8581000	shares
CY2011Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.18
CY2011Q3	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-0.20
CY2011Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	8581000	shares
CY2011Q3	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	-0.20
CY2011Q3	us-gaap	Net Income Loss NetIncomeLoss	-1555000
CY2011Q3	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	-1743000
CY2011Q3	us-gaap	Sales Revenue Net SalesRevenueNet	26177000
CY2011Q3	ssy	Minimum Amount Through Private Placement Of Shares MinimumAmountThroughPrivatePlacementOfShares	2500000
CY2011Q3	ssy	Common Shares Sought To Sell In Private Offering CommonSharesSoughtToSellInPrivateOffering	3800000	shares
CY2011Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.10
CY2011Q4	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	9448000	shares
CY2011Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.10
CY2011Q4	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-0.15
CY2011Q4	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	9448000	shares
CY2011Q4	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	-0.15
CY2011Q4	us-gaap	Net Income Loss NetIncomeLoss	-935000
CY2011Q4	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	-1397000
CY2011Q4	us-gaap	Sales Revenue Net SalesRevenueNet	29025000
CY2012Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.15
CY2012Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	9446000	shares
CY2012Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.15
CY2012Q3	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-0.17
CY2012Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	9446000	shares
CY2012Q3	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	-0.17
CY2012Q3	us-gaap	Net Income Loss NetIncomeLoss	-1424000
CY2012Q3	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	-1622000
CY2012Q3	us-gaap	Sales Revenue Net SalesRevenueNet	25690000
CY2012Q3	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	789000
CY2012Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.42
CY2012Q4	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	9446000	shares
CY2012Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.42
CY2012Q4	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-0.15
CY2012Q4	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	9446000	shares
CY2012Q4	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	-0.15
CY2012Q4	us-gaap	Net Income Loss NetIncomeLoss	3935000
CY2012Q4	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	-1395000
CY2012Q4	us-gaap	Sales Revenue Net SalesRevenueNet	27850000

Files In Submission

Name	View Source	Status
0001193125-13-382169-index-headers.html	Edgar Link	pending
0001193125-13-382169-index.html	Edgar Link	pending
0001193125-13-382169.txt	Edgar Link	pending
0001193125-13-382169-xbrl.zip	Edgar Link	pending
d553642d10k.htm	Edgar Link	pending
d553642dex1029.htm	Edgar Link	pending
d553642dex1030.htm	Edgar Link	pending
d553642dex211.htm	Edgar Link	pending
d553642dex231.htm	Edgar Link	pending
d553642dex311.htm	Edgar Link	pending
d553642dex312.htm	Edgar Link	pending
d553642dex321.htm	Edgar Link	pending
d553642dex322.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xls	Edgar Link	pending
g553642g80t64.jpg	Edgar Link	pending
R1.htm	Edgar Link	pending
R1.xml	Edgar Link	unprocessable
R10.htm	Edgar Link	pending
R10.xml	Edgar Link	unprocessable
R11.htm	Edgar Link	pending
R11.xml	Edgar Link	unprocessable
R12.htm	Edgar Link	pending
R12.xml	Edgar Link	unprocessable
R13.htm	Edgar Link	pending
R13.xml	Edgar Link	unprocessable
R14.htm	Edgar Link	pending
R14.xml	Edgar Link	unprocessable
R15.htm	Edgar Link	pending
R15.xml	Edgar Link	unprocessable
R16.htm	Edgar Link	pending
R16.xml	Edgar Link	unprocessable
R17.htm	Edgar Link	pending
R17.xml	Edgar Link	unprocessable
R18.htm	Edgar Link	pending
R18.xml	Edgar Link	unprocessable
R19.htm	Edgar Link	pending
R19.xml	Edgar Link	unprocessable
R2.htm	Edgar Link	pending
R2.xml	Edgar Link	unprocessable
R20.htm	Edgar Link	pending
R20.xml	Edgar Link	unprocessable
R21.htm	Edgar Link	pending
R21.xml	Edgar Link	unprocessable
R22.htm	Edgar Link	pending
R22.xml	Edgar Link	unprocessable
R23.htm	Edgar Link	pending
R23.xml	Edgar Link	unprocessable
R24.htm	Edgar Link	pending
R24.xml	Edgar Link	unprocessable
R25.htm	Edgar Link	pending
R25.xml	Edgar Link	unprocessable
R26.htm	Edgar Link	pending
R26.xml	Edgar Link	unprocessable
R27.htm	Edgar Link	pending
R27.xml	Edgar Link	unprocessable
R28.htm	Edgar Link	pending
R28.xml	Edgar Link	unprocessable
R29.htm	Edgar Link	pending
R29.xml	Edgar Link	unprocessable
R3.htm	Edgar Link	pending
R3.xml	Edgar Link	unprocessable
R30.htm	Edgar Link	pending
R30.xml	Edgar Link	unprocessable
R31.htm	Edgar Link	pending
R31.xml	Edgar Link	unprocessable
R32.htm	Edgar Link	pending
R32.xml	Edgar Link	unprocessable
R33.htm	Edgar Link	pending
R33.xml	Edgar Link	unprocessable
R34.htm	Edgar Link	pending
R34.xml	Edgar Link	unprocessable
R35.htm	Edgar Link	pending
R35.xml	Edgar Link	unprocessable
R36.htm	Edgar Link	pending
R36.xml	Edgar Link	unprocessable
R37.htm	Edgar Link	pending
R37.xml	Edgar Link	unprocessable
R38.htm	Edgar Link	pending
R38.xml	Edgar Link	unprocessable
R39.htm	Edgar Link	pending
R39.xml	Edgar Link	unprocessable
R4.htm	Edgar Link	pending
R4.xml	Edgar Link	unprocessable
R40.htm	Edgar Link	pending
R40.xml	Edgar Link	unprocessable
R41.htm	Edgar Link	pending
R41.xml	Edgar Link	unprocessable
R42.htm	Edgar Link	pending
R42.xml	Edgar Link	unprocessable
R43.htm	Edgar Link	pending
R43.xml	Edgar Link	unprocessable
R44.htm	Edgar Link	pending
R44.xml	Edgar Link	unprocessable
R45.htm	Edgar Link	pending
R45.xml	Edgar Link	unprocessable
R46.htm	Edgar Link	pending
R46.xml	Edgar Link	unprocessable
R47.htm	Edgar Link	pending
R47.xml	Edgar Link	unprocessable
R48.htm	Edgar Link	pending
R48.xml	Edgar Link	unprocessable
R49.htm	Edgar Link	pending
R49.xml	Edgar Link	unprocessable
R5.htm	Edgar Link	pending
R5.xml	Edgar Link	unprocessable
R50.htm	Edgar Link	pending
R50.xml	Edgar Link	unprocessable
R51.htm	Edgar Link	pending
R51.xml	Edgar Link	unprocessable
R52.htm	Edgar Link	pending
R52.xml	Edgar Link	unprocessable
R53.htm	Edgar Link	pending
R53.xml	Edgar Link	unprocessable
R54.htm	Edgar Link	pending
R54.xml	Edgar Link	unprocessable
R55.htm	Edgar Link	pending
R55.xml	Edgar Link	unprocessable
R56.htm	Edgar Link	pending
R56.xml	Edgar Link	unprocessable
R57.htm	Edgar Link	pending
R57.xml	Edgar Link	unprocessable
R58.htm	Edgar Link	pending
R58.xml	Edgar Link	unprocessable
R59.htm	Edgar Link	pending
R59.xml	Edgar Link	unprocessable
R6.htm	Edgar Link	pending
R6.xml	Edgar Link	unprocessable
R60.htm	Edgar Link	pending
R60.xml	Edgar Link	unprocessable
R61.htm	Edgar Link	pending
R61.xml	Edgar Link	unprocessable
R62.htm	Edgar Link	pending
R62.xml	Edgar Link	unprocessable
R63.htm	Edgar Link	pending
R63.xml	Edgar Link	unprocessable
R64.htm	Edgar Link	pending
R64.xml	Edgar Link	unprocessable
R65.htm	Edgar Link	pending
R65.xml	Edgar Link	unprocessable
R66.htm	Edgar Link	pending
R66.xml	Edgar Link	unprocessable
R67.htm	Edgar Link	pending
R67.xml	Edgar Link	unprocessable
R68.htm	Edgar Link	pending
R68.xml	Edgar Link	unprocessable
R69.htm	Edgar Link	pending
R69.xml	Edgar Link	unprocessable
R7.htm	Edgar Link	pending
R7.xml	Edgar Link	unprocessable
R70.htm	Edgar Link	pending
R70.xml	Edgar Link	unprocessable
R71.htm	Edgar Link	pending
R71.xml	Edgar Link	unprocessable
R72.htm	Edgar Link	pending
R72.xml	Edgar Link	unprocessable
R73.htm	Edgar Link	pending
R73.xml	Edgar Link	unprocessable
R74.htm	Edgar Link	pending
R74.xml	Edgar Link	unprocessable
R75.htm	Edgar Link	pending
R75.xml	Edgar Link	unprocessable
R76.htm	Edgar Link	pending
R76.xml	Edgar Link	unprocessable
R77.htm	Edgar Link	pending
R77.xml	Edgar Link	unprocessable
R78.htm	Edgar Link	pending
R78.xml	Edgar Link	unprocessable
R79.htm	Edgar Link	pending
R79.xml	Edgar Link	unprocessable
R8.htm	Edgar Link	pending
R8.xml	Edgar Link	unprocessable
R9.htm	Edgar Link	pending
R9.xml	Edgar Link	unprocessable
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
ssy-20130630.xml	Edgar Link	completed
ssy-20130630.xsd	Edgar Link	pending
ssy-20130630_cal.xml	Edgar Link	unprocessable
ssy-20130630_def.xml	Edgar Link	unprocessable
ssy-20130630_lab.xml	Edgar Link	unprocessable
ssy-20130630_pre.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$SSY
SUNLINK HEALTH SYSTEMS INC Stock $ssy

2013 Q2 Form 10-K Financial Statement

#000119312513382169 Filed on September 27, 2013

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SSY SUNLINK HEALTH SYSTEMS INC Stock $ssy

2013 Q2 Form 10-K Financial Statement

#000119312513382169 Filed on September 27, 2013

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SSY
SUNLINK HEALTH SYSTEMS INC Stock $ssy